Notably, although CD147 knockdown per se delayed tumor progression to a lesser extent, the combination of CD147 knockdown and paclitaxel treatment significantly shrunk the tumors (Fig. 2G and Supplementary Fig. 1F–H), suggesting that CD147 knockdown sensitizes cancer cells to paclitaxel. The gene discussed is BSG; the disease is neoplasm.